CaseyMcdonaldCosgroveMD
Obstetrics & Gynecology • Hilliard, OHGynecologic Oncology
Assistant Professor
Dr. Cosgrove is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3651 Ridge Mill Dr
Hilliard, OH 43026Phone+1 614-293-3873Fax+1 614-293-3078
Summary
- I am a gynecologic oncologist at the Ohio State University/James Cancer Hospital. My research focus is in endometrial cancer, specifically molecular classification and risk stratification.
Education & Training
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2016 - 2019- Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2013 - 2016
Florida State University College of MedicineClass of 2012
Certifications & Licensure
OH State Medical License 2012 - 2025- OH State Medical License 2016 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Courage to Teach Award 2018
- GOG Young Investigator Travel Award 2018
- The Ohio State University Obstetrics and Gynecology Resident Teaching Award 2013-2014, 2016
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEpigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer.Courtney J Riedinger, Morgan Brown, Paulina J Haight, Floor J Backes, David E Cohn
Frontiers in Oncology. 2023-01-01 - 14 citationsThe right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.Paulina J Haight, Courtney J Riedinger, Floor J Backes, David M O'Malley, Casey M Cosgrove
Gynecologic Oncology. 2023-08-01 - 9 citationsPhase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal cancerFloor J. Backes, Lai Wei, Min Chen, Kasey Hill, Kyle Dzwigalski
Gynecologic Oncology. 2019-06-01
Press Mentions
A Third of Women Can't Identify This Common Symptom of Endometrial CancerSeptember 6th, 2024- Hormonal Therapies for Endometrial Cancer in the Molecular EraJune 7th, 2024
Society of Gynecologic Oncology 50th Anniversary: Casey Cosgrove, MDNovember 8th, 2019- Join now to see all
Professional Memberships
- Member
- Member
- Society of Gynecologic OncologyMember
- Gold Humanism Honor SocietyMember
- International Gynecologic Cancer SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
